Tag: Tony Cunningham

The below Parliamentary question was asked by Tony Cunningham on 2015-01-14.

To ask the Secretary of State for Health, how the Government’s approach to negotiating a cost-effective price for the meningococcal B vaccine Bexsero takes account of fluctuations in disease levels characteristic of that virus and the recent emergence of another strain of meningitis which may be treated using Bexsero.

Jane Ellison

The independent cost-effectiveness analysis of the use of the meningococcal B vaccine, Bexsero took account of the incidence and case fatality rates of all meningococcal disease, including meningococcal W in England during the period 2005-06 to 2011-12. The Joint Committee on Vaccination and Immunisation (JCVI) considered that these data gave a reasonable range. JCVI are the independent experts responsible for advising the Government on immunisations following due consideration of the evidence on the burden of disease, vaccine safety and efficacy and cost effectiveness.

Further information is available in Christensen H, Trotter CL, Hickman M, Edmunds WJ. Re‑evaluating cost effectiveness of universal meningitis vaccination (Bexsero) in England: modelling study. BMJ 2014; 349: g5725.

The below Parliamentary question was asked by Tony Cunningham on 2015-01-14.

To ask the Secretary of State for Health, which post in his Department is responsible for leading negotiations on setting a cost-effective price for the meningococcal B vaccine Bexsero; and when the next meeting to continue those negotiations is scheduled.

Jane Ellison

The Department’s Director General for Innovation, Growth and Technology is leading negotiations with the manufacturer for the supply of the meningococcal B vaccine, Bexsero. The most recent negotiating meeting took place on 8 December 2014 and, following subsequent technical discussions, the next such meeting will take place shortly.

The below Parliamentary question was asked by Tony Cunningham on 2014-06-04.

To ask the Secretary of State for Justice, for what reasons legal aid funding in relation to the case of the constituent of the hon. Member for Workington, Gary Tomlinson, Claim Number OWH0080, Cert number JBIRQK61BB77/A/E/1, was withdrawn.

Mr Shailesh Vara

The receipt of legal aid is considered to be personal data and the Department has obligations under the Data Protection Act 1998 which would prevent it from disclosing this type of information. Furthermore, the Legal Aid Agency is further prohibited by statute from disclosing information relating to the provision of legal aid in individual cases (under section 34 of the LASPO Act 2012, section 20 of the Access to Justice Act 1999, and before this under section 38 of the Legal Aid Act 1988).